SEC Form 15-12G filed by Cyclo Therapeutics Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-39780
CYCLO THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
6714 NW 16th Street, Suite B
Gainesville, Florida 32653
(386) 418-8060
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
|
Common Stock, par value $.0001 per share |
CYTH |
The Nasdaq Stock Market LLC |
|
Warrants to purchase Common Stock |
CYTHW |
The Nasdaq Stock Market LLC |
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1) |
☒ |
||
|
Rule 12g-4(a)(2) |
☐ |
||
|
Rule 12h-3(b)(1)(i) |
☒ |
||
|
Rule 12h-3(b)(1)(ii) |
☐ |
||
|
Rule 15d-6 |
☐ |
||
|
Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification or notice date of the Common Stock: 1
Approximate number of holders of record as of the certification or notice date of the Warrants: None
Pursuant to the requirements of the Securities Exchange Act of 1934, Cyclo Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
CYCLO THERAPEUTICS, INC. |
|||
|
Date: April 7, 2025 |
By: |
/s/ N. Scott Fine |
|
|
Name: |
N. Scott Fine |
||
|
Title: |
Chief Executive Officer |
||